ONC Health IT Costs and Limitations Disclosures
The following Disclosures apply to the DOX EMR EHR system product:
“This Health IT Module is 2015 Edition compliant and has been certified by an ONC-ACB in accordance with the applicable certification criteria adopted by the Secretary of Health and Human Services. This certification does not represent an endorsement by the U.S. Department of Health and Human Services.”
· Company Name: DOX/ Starwriter
· Date Certified: 3/15/18
· Product Name and Version: DOX EMR V 5.2.0
· Unique certification number : IG-4087-18-0012
· Certification criterion or criteria to which each EHR module has been tested and certified: 2015 Edition Ambulatory - listed below
· Clinical quality measures to which a complete EHR or EHR module has been tested and certified: 2015 standards CQMs - specific measures listed below.
· Additional types of costs that a user may be required to pay to implement or use the Complete EHR capabilities, whether to meet meaningful use objectives and measures or to achieve any other use within the scope of the health IT's certification. Additional costs include: Acrendo/ New Crop is utilized and built directly into the application to provide e-RX functionality. EMR Direct is utilized and built directly into the application to provide Direct messaging. Both of these costs are built directly into the recurring monthly fee.
Contractual Limitations: There are no contractual limitations on the use of any of the capabilities to which the DOX technology is certified for any purpose within the scope of the technology's certification for providers to obtain meaningful use, MIPS requirements or other government payment initiatives. Starwriter/DOX does reserve the right to utilize any data generated by providers, in the course of using the DOX system, in De-identified/ HIPAA compliant form, for the purposes of medical outcome studies, medical research or any venue utilizing data from the system to support and further evidence based medicine and value based care. Data used by a provider using the DOX system, for any other purpose other than patient care or to obtain meaningful use, MIPS requirements , must be approved in writing by Starwriter/DOX.
Technical Limitations: additional software the complete EHR uses to demonstrate its compliance with certification criterion: Acrendo/ New Crop is utilized and built directly into the application to provide e-RX functionality.
EMR Direct is utilized to provide Direct messaging functionality- external API at: https://doxweb.doxemr.com/DoxEXTAPI/Help
Additional External API details: https://doxweb.doxemr.com/DoxExtAPI/DOXAPI-Application-Access.pdf
There are no other known limitations ( by contract or otherwise) that a user may encounter in the course of implementing and using the Complete EHR or Health IT Module's capabilities, to meet meaningful use objectives and measures or to achieve any other use within the scope of the health IT's certification.
The above information pertains to DOX EMR V 5.2.0.
** R = Measure removed by ONC from 2015 certification criteria
Criteria qualified: CQMs qualified:
170.315 (a)(1): Computerized Provider Order Entry (CPOE) - Medications
170.315 (a)(2): CPOE - Laboratory CMS22: Preventive Care and Screening: Screening
170.315 (a)(3): CPOE - Diagnostic Imaging for High Blood Pressure and Follow-Up Documented
170.315 (a)(4): Drug-Drug, Drug-Allergy Interaction Checks for CPOE
170.315 (a)(5): Demographics CMS68: Documentation of Current Medications in
170.315 (a)(6): Problem List R the Medical Record
170.315 (a)(7): Medication List R CMS69: Preventive Care and Screening: Body Mass
170.315 (a)(8): Medication Allergy List R Index (BMI) Screening and Follow-Up Plan
170.315 (a)(9): Clinical Decision Support CMS117: Childhood Immunization Status
170.315 (a)(10): Drug-Formulary and Preferred Drug List Checks
170.315 (a)(11): Smoking Status R CMS122: Diabetes: Hemoglobin A1c (HbA1c) Poor
170.315 (a)(12): Family Health History Control (> 9%)
170.315 (a)(13): Patient-Specific Education Resources CMS123: Diabetes: Foot Exam
170.315 (a)(14): Implantable Device List
170.315 (b)(1): Transitions of Care CMS138: Preventive Care and Screening: Tobacco
170.315 (b)(4): Common Clinical Data Set Summary Record - Create R Use: Screening and Cessation Intervention
170.315 (b)(5): Common Clinical Data Set Summary Record - Receive R CMS139: Falls: Screening for Future Fall Risk
170.315 (b)(6): Data Export
170.315 (b)(9): Care Plan CMS147: Preventive Care and Screening: Influenza
170.315 (c)(1): Clinical Quality Measures - Record and Export Immunization
170.315 (c)(2): Clinical Quality Measures - Import and Calculate CMS164: Ischemic Vascular Disease (IVD): Use of
170.315 (c)(3): Clinical Quality Measures - Report Aspirin or Another Antiplatelet
170.315 (d)(1): Authentication, Access Control, Authorization CMS165: Controlling High Blood Pressure
170.315 (d)(2): Auditable Events and Tamper-Resistance
170.315 (d)(3): Audit Report(s) CMS166: Use of Imaging Studies for Low Back Pain
170.315 (d)(4): Amendments
170.315 (d)(5): Automatic Access Time-out
170.315 (d)(6): Emergency Access
170.315 (d)(7): End-User Device Encryption
170.315 (d)(8): Integrity
170.315 (d)(9): Trusted Connection
170.315 (g)(2): Automated Measure Calculation
170.315 (g)(3): Safety-Enhanced Design
170.315 (g)(4): Quality Management System
170.315 (g)(5): Accessibility-Centered Design
170.315 (g)(6): Consolidated CDA Creation
170.315 (g)(7): Application Access - Patient Selection
170.315 (g)(8): Application Access - Data Category Request
170.315 (g)(9): Application Access - All Data Request
170.315 (h)(1): Direct Project